Here's why Iluka Resources Limited shares surged today

Iluka Resources Limited (ASX:ILU) impresses investors with a 111% increase in the full year dividend. Is it time to buy?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Mineral sands producer Iluka Resources Limited (ASX: ILU) has seen its share price surge over 6% during trading today after the release of full year results and a substantial increase in the final dividend.

Iluka posted an after tax loss of $62.5 million compared with a $18.5 million profit in the prior year. Profit was affected heavily by the $86.5 million non-cash impairment charge related to the expected closure of its U.S. Virginia operations.

The final fully franked dividend of 13c a share brought the full year dividend to 19c, up 111% on the previous year.

Revenue of $724.9 million was 5.0% lower than the previous year. The 5.4% increase in sales volume of its main products zircon, rutile and synthetic rutile, was offset by falling prices. During the year, the average realised price of zircon and rutile dropped 10% and 25%, respectively.

Strong free cash flow of $196.3 million allowed Iluka to reduce long term debt by 71.4%, ending the year with $59.0 million on the balance sheet.

Helping the final year result was an approximate $80 million draw-down of inventory, because Iluka sold 81kt more product than it produced during the year. Managing director David Robb indicated inventory draw down may continue into 2015.

Mr Robb commented that: "2014 was a year in which the financial health of the company was preserved and in which foundations were laid for recovery in the existing business and new options were secured for future growth. But reported profit was not satisfactory."

Iluka delivered a solid result in what was a tough period for commodity producers. A significant reduction in debt has strengthened the company finances and the availability of large credit facilities could allow it to pursue favourable acquisitions in the near-future. Inventory draw-down can help support revenue in the short term but it is not sustainable in the long term.

Whilst the large increase in dividend may have wooed investors hungry for yield, the future profits (and dividends) of Iluka are tied to volatile commodity prices and I would recommend leaving this company on the watchlist for now.

Motley Fool contributor Mitch Sonogan does not own shares in any company mentioned.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »